In this Section |
226513 Strategic engagement of policymakers to advance a children's health care coverage policy agendaTuesday, November 9, 2010
Policymakers can be critically important allies of children's advocates. As part of an evaluation of the David and Lucile Packard Foundation's Insuring America's Children: States Leading the Way grantmaking strategy, researchers conducted site visits to seven states—Arkansas, Colorado, Iowa, Ohio, Rhode Island, Texas and Washington—and found that the establishment of strong relationships between advocacy organizations and policymakers is central to not only moving children's health care coverage agendas forward, but also to preserving previous coverage gains. Understanding states' unique political environments is an important first step for advocates in developing effective strategies to engage policymakers and gain their support. Additional critical strategies include: identifying, nurturing and supporting political champions; creating strategic linkages between grassroots and policy advocacy; using effective and positive messaging that appeals to policymakers; establishing advocacy organizations as the “go to” resource for reliable data and information; and, sharing ownership of agendas and successes with policymakers. This paper describes how advocates in the seven states have used these strategies and provides useful lessons for other advocates pursuing expansions in health insurance coverage.
Learning Areas:
Advocacy for health and health educationOther professions or practice related to public health Public health or related public policy Learning Objectives: Keywords: Children's Health, Advocacy
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have significant experience directing evaluation and technical assistance projects related to maternal and child health, Medicaid, SCHIP, and children with special health care needs. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4235.0: Infant and Child Health Poster Session
|